Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.3650
-0.0050 (-1.35%)
At close: Jul 18, 2025, 4:00 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 47.55 million as of July 18, 2025. Its market cap has decreased by -15.91% in one year.
Market Cap
47.55M
Enterprise Value
40.23M
Revenue
210.81K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 47.55M, an increase of 85.00%. That is a compound annual growth rate of 37.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 47.55M | 4.23% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 120.27B |
| Pro Medicus | 34.52B |
| Cochlear | 20.09B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 8.32B |
| Ansell | 4.42B |
| Mesoblast | 2.29B |